Table 1:
Patient | Sex | Age (yr) | Pathology | Status |
---|---|---|---|---|
1 | Male | 51 | Glioblastoma, astrocytic, gemistocytic | Postbiopsy, postradiation (6 mo)a |
2 | Male | 53 | Glioblastoma, astrocytic, small cell | Postbiopsy, postradiation (8 mo)a |
3 | Male | 84 | Glioblastoma, astrocytic, small cell | Prebiopsy, preradiation |
4 | Male | 66 | Glioblastoma, astrocytic, gemistocytic | Prebiopsy, preradiation |
5 | Male | 55 | Primary CNS lymphoma, large B-cell | Postbiopsy, preradiation |
6 | Female | 74 | Primary CNS lymphoma, large B-cell | Prebiopsy, preradiation |
7 | Male | 67 | Primary CNS lymphoma, large B-cell | Prebiopsy, preradiation |
8 | Female | 72 | Metastatic adenocarcinoma, primary colon | Prebiopsy, postradiosurgery (14 mo)a |
9 | Male | 58 | Metastatic renal cell carcinoma | Prebiopsy, postradiosurgery (10 mo)a |
10 | Female | 73 | Metastatic non-small cell lung | Prebiopsy, postradiosurgery (6 mo)a |
Interval in months between radiation treatment and MRI.